Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy

Detalles Bibliográficos
Autores principales: Oner, Gizem, Önder, Semen, Karatay, Hüseyin, Ak, Naziye, Tükenmez, Mustafa, Müslümanoğlu, Mahmut, İğci, Abdullah, Dincçağ, Ahmet, Özmen, Vahit, Aydiner, Adnan, Yavuz, Ekrem, Cabioğlu, Neslihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942286/
https://www.ncbi.nlm.nih.gov/pubmed/36810121
http://dx.doi.org/10.1186/s12957-023-02931-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942286/
https://www.ncbi.nlm.nih.gov/pubmed/36810121
http://dx.doi.org/10.1186/s12957-023-02931-z

Ejemplares similares